Basel Medical Group Begins Exclusive Negotiations For $1B BTC Acquisition To Diversify Treasury Reserves, While Maintaining Core Focus On Medical Services Expansion

Basel Medical Group Ltd (NASDAQ:BMGL), today announced that it has begun exclusive negotiations for a US$1 billion BTC acquisition that will diversify its treasury reserves to a very large extent, while maintaining its core focus on medical services expansion. This is a major strategic financial initiative to strengthen its balance sheet and support its aggressive expansion across Asia's high-growth healthcare markets.

Strategic Financial Restructuring for Growth

BMGL is in advanced discussions with a consortium of institutional investors and high-net-worth individuals, who are influential in the crypto space, to acquire a US$1 billion BTC through an innovative share-swap arrangement. Management believes that this landmark transaction, if successful, will represent one of the largest corporate balance sheet enhancements in the Asia-Pacific healthcare sector.

Strengthening the Foundation for Regional Expansion

The proposed US$1 billion capital infusion will:

• Create one of the strongest balance sheets among Asia-focused healthcare providers;
• Provide unmatched financial flexibility for mergers and acquisitions;
• Establish a diversified asset base to weather market volatility; and
• Position BMGL as a well-capitalized medical group in emerging Asian markets

The Company expects to finalize terms this current quarter, subject to standard closing conditions and regulatory approvals.